Breaking News

Burning questions for Moderna CEO at Senate hearing; small rise in breast cancer risk seen with most hormonal birth control

March 21, 2023
Moderna pharmaceutical and biotechnology company's CEO  Stéphane Bancel will appear alone before Sen. Bernie Sanders' health committee on Wednesday.
JOEL SAGET/AFP via Getty Images

STAT+ | 8 burning questions Bernie Sanders and other senators should ask Moderna's Stéphane Bancel

How exactly did you land on $130 for a Covid vaccine dose? And 7 other burning questions for Moderna CEO Stéphane Bancel.

By Helen Branswell and Rachel Cohrs and Damian Garde


Methadone doses haven't kept up in the age of fentanyl. A new rule aims to help

A new federal regulation would make it easier for some patients to begin addiction treatment on significantly higher doses of methadone.

By Lev Facher


Study finds same small rise in breast cancer risk in many forms of hormonal birth control

The absolute increased risk is small for all such birth control, but the study throws into question the idea that it is lower for IUDs.

By Angus Chen



AppliedVR, a company targeting chronic pain, has become the first digital therapeutic to secure Medicare coverage as durable medical equipment.
Courtesy AppliedVR

STAT+ | A new Medicare ruling could give virtual reality companies an easier path to payment

Medicare officials granted AppliedVR a unique code for its product, RelieVRx, and placed it in the durable medical equipment category.

By Lizzy Lawrence


STAT+ | Altimmune's obesity drug fails to stand out from blockbuster treatments in early data

Mid-stage trial data on Altimmune's obesity drug showed it doesn't have a leg up on other popular drugs on the market.

By Allison DeAngelis


Steroid drug reduces death rate in severe pneumonia, study shows

The results will challenge current treatment guidelines, which advise against the use of corticosteroids in community acquired pneumonia

By Matthew Herper


Biosafety protective suits outside a chemical decontamination room in a biosafety level 4 training facility at U.S. Army Medical Research and Development Command at Fort Detrick in Frederick, Md.
Andrew Harnik/AP

Opinion: The lab leak conversation shows it's time to rethink our biosecurity infrastructure, not just policies

New proposals to combat biosecurity threats are being shoehorned into an infrastructure that was designed to keep science apart from society.

By Sam Weiss Evans and David Gillum


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments